Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
697
-
Total 13F shares, excl. options
-
264,324,002
-
Shares change
-
+259,940,293
-
Total reported value, excl. options
-
$7,785,299,734
-
Value change
-
+$7,652,922,694
-
Put/Call ratio
-
55%
-
Number of buys
-
655
-
Number of sells
-
54
-
Price
-
$29.43
Institutional Holders of GSK plc - SPONSORED ADR (GSK) as of Q3 2022
As of 30 Sep 2022 GSK plc - SPONSORED ADR (GSK) had 771 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 264,324,002 shares of stock of the company.
Largest 10 holders included Dodge & Cox, FMR LLC, Fisher Asset Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, STATE STREET CORP, and TWO SIGMA INVESTMENTS, LP.
This table shows 771 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.